Cardiovascular Dynamics

Last updated : 18/10/2024 - 378 views

The Cardiovascular Dynamics section is led by Michelle Chew.

CD News

ESICM Guidelines on End-of-Life and Palliative Care in the intensive care unit
ARTICLE
699 views
Presenting the new highly anticipated recommendations and expert opinions on end-of-life (EoL) and palliative care…
Environmental sustainability in intensive care: the path forward. An ESICM Green Paper
ARTICLE
344 views
At LIVES 2024, ESICM proudly launched the Green Paper on Environmental Sustainability, marking a significant…

Resources

Education

Progressive courses in Haemodynamic monitoring

The novelty for 2023 is the progressive approach for better integration of what is being learnt in Haemodynamics, offering our participants the possibility to choose based on their needs, skill and aims.

  • Level 1: Foundation Course (introductory)
  • Format: Virtual
  • Dates: 5-6 December, 2023
  • Level 2: Transition Course
  • Format: Virtual
  • Dates: 2-3 May, 2024
Progressive courses in ECLS/ECMO

The novelty for 2023 is the progressive approach for better integration of what is being learnt in ECLS/ECMO, offering our participants the possibility to choose based on their needs, skill and aims.

These courses are part of a joint EuroELSO & ESICM programme to provide specialised training in extracorporeal techniques to healthcare professionals interested in the field. Certificates may be validated at EuroELSO on the path to the ELSO Adult ECMO Practitioner Certification (E-AEC).

These courses will bring together a panel of worldwide known EuroELSO & ESICM experts.

  • Level 1: Foundation Course
  • Format: Virtual
  • Dates: 14-15 March, 2024
  • Level 3: Pre-congress course at LIVES 2023 (Milan, Italy)
  • Dates: 11-12 June, 2024
Webinars

Free live webinars are available for members & non members on the ESICM Media Library.

Research

Projects

SICU II

Sepsis in the ICU-II: Precision medicine models for sepsis-induced myocardial dysfunction

Aims:
To determine the association between left and right ventricular systolic and diastolic dysfunction (Aim 1), novel biomarkers (Aim 2) and adverse outcome in SIMD. Finally, we will determine the combined value of clinical, biomarker, echocardiographic, and haemodynamic variables (Aim 3). Adverse outcomes are defined as acute myocardial injury (Effect 1), days free of organ support (Effect 2), 30-day mortality (Effect 3) and days alive and out of hospital at 30 days after ICU admission (Effect 4). We will use traditional statistical inference based on standard multivariable and mixed model analysis to explore the prognostic significance of individual and combined predictor variables.

(2) A machine learning algorithm to identify important features for prediction of short- and long-term mortality: To use an ensemble tree-based machine learning approach to identify the most important features (i.e. variables), among a set of supplied features, that can predict mortality, and examine how each feature alters the prior expectation of ICU outcome (Aim 4, Effect 5).
(3) Consensus definition of sepsis-induced myocardial dysfunction: Combining the results of our studies with current literature, we will invite key opinion leaders within the field to formulate a consensus for the definition, management and future research priorities for SIMD (Aim 5).

FOR MORE INFORMATION, PLEASE CONTACT Michelle Chew Dept of Anaesthesia and Intensive Care, Linköping University Hospital, S58185, Sweden. Michelle.chew [ @ ] liu.se 

FENICE II

Fluid Challenge in Intensive Care: a worldwide global inception cohort study.

Aims:
Primary aim: The primary aim is to describe the modality of fluid administration during the first 5 days of ICU stay considering 1) the overall fluid balance; 2) the characteristics of the fluids given; 3) the modality of fluid administration.

Secondary aims:

  • To explore any association between fluid administration characteristics and clinical outcomes (see further)
  • To evaluate factors potentially associated with the respective proportion of the different modalities of fluid administration
  • To characterize FC administration modality in a large cohort of ICU patients.

Clinical outcomes:

  • In-hospital, intensive care unit, and 30-day mortality.
  • Major organ dysfunction: lungs, heart and circulatory system, kidneys.
  • Variation in SOFA score within 7 days from admission.

Functional outcomes:

  • Volume of resuscitation fluids within 5 days from admission, type of fluid, and modality of administration.

Net daily fluid balance within 5 days.

Objectives:

To describe the fluid challenge administration modality and appraise the use of variables and functional haemodynamic tests to guide bolus infusion.

To provide a comprehensive global description of fluid administration modalities during the initial days of ICU admission and to explore any association between fluid administration characteristics and clinical outcomes.

FENICE

FENICE (Fluid Challenges in Intensive Care) is a multicentre observational trial designed and conducted by the ESICM Trials Group to investigate how fluids are administered in critically ill patients.

The purpose of this study is to evaluate how fluids are administered and how frequently fluid administration results in a positive haemodynamic response.

Fluid challenges in intensive care: the FENICE study – A global inception cohort study.

The ICU CardioMan Study

Cardiovascular Monitoring & Management in Austrian, German and Swiss Intensive Care Units. The objective of this multicentre study was to analyse the reality of haemodynamic monitoring and therapy of the critically ill in Austrian, German and Swiss intensive care units. This included acquisition of data on which types of haemodynamic monitoring clinicians have available in their ICU.

This study also aimed to investigate which indications lead to therapy decisions and/or extension of haemodynamic monitoring and which parameters serve as therapeutic goals. Additionally, this study investigated how the extension of haemodynamic monitoring guides and modifies therapeutic decisions and strategies in clinical practice.

Funcke S et al. Practice of haemodynamic monitoring and management in German, Austrian, and Swiss intensive care units: the multicentre cross-sectional ICU-CardioMan Study.

Project Groups
  • ECHO Project Group: VIEILLARD-BARON Antoine
    • To promote and support research and education on echocardiography in ICU.
  • Haemodynamic monitoring: MONNET Xavier
    • To promote and support research and education on haemodynamic monitoring in ICUs.
  • Monitoring of sublingual microcirculation
Surveys

UCARDS

Use of CARdiovascular Drugs in Shock. In shock, organs are hypoperfused leading to dysfunction or death at a cellular level, as well as disruption in cardiovascular functions. Cardiovascular drugs are often used to manage patients in this state, despite the lack of consensus on their use.

This survey from the Cardiovascular Dynamics Section aimed to evaluate the indications, current practice, and therapeutic goals in European ICUs on the use of cardiovascular drugs in the treatment of shock states.

Publication: Scheeren T.W.L et al. 2019. Current use of vasopressors in septic shock

Intra-abdominal Hypertension and Abdominal Compartment Syndrome World Survey.

This survey, endorsed by ESICM and WSACS, is part of a research project which aims to determine the impact, if any, of the 2013 World Society of the Abdominal Compartment Syndrome (WSACS) IAH/ACS Consensus Definitions/Clinical Management Guidelines, IAP measurement practices, on IAH/ACS clinical awareness and management.

Results from this survey will be compared with those obtained from a similar survey conducted in 2007.

This project was conducted by Dr RD Wise, a member of the WSCAS Clinical Trials Working Group, supported by WSACS and led by Pr Manu Malbrain.

Red Cell Transfusion

Variation in red cell transfusion practice in the ICU: an international survey.

The INOX-ICU 1 team: S. A Willems Bsc, Sesmu Arbous MD/PhD, Prof. J. Kesecioglu MD/PhD, Prof. J. van der Bom MD/PhD, Prof. S. le Cessie PhD, P.J. Marang-van de Mheen PhD, F. Kranenburg MD/PhD

This survey aims to estimate the extent of variation in transfusion decisions within four clinical scenarios. This knowledge can add to further improve personalised care with respect to transfusion practice in critically ill patients.

Relevant Literature
Article Reviews

A new perspective for Oxygen Therapy in Suspected Acute Myocardial Infarction
The DETO2X-AMI is the largest trial to date investigating the effect of oxygen therapy in patients with suspected IMA with no hypoxaemia at baseline, both in the prehospital and hospital setting.

Angiotensin II for the Treatment of Vasodilatory Shock
Vasodilatory shock is a severe clinical condition characterised by acute reduction of vascular resistance leading to systemic hypoperfusion, multi-organ dysfunction and death.

Conservative fluid management: Turn off the tap after use?
In the recently published updated guidelines by the Surviving Sepsis Campaign, fluid administration is the mainstay of initial resuscitation of septic patients and it should be performed early

Restricting volumes of resuscitation fluid in adults with septic shock: CLASSIC Trial
The administration of fluid optimises intravascular volume and perfusion pressure of vital organs, excessive fluid administration can be detrimental.

Cardiac output measurements: Echocardiography vs. thermodilution
The clinical standard is considered to be intermittent thermodilution technique based on the Stewart–Hamilton equation. This technique has its limitations, including variability in serial measurements of CO and rare, but potentially serious, complications.